Synthetic Biology Market By Tool 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Synthetic Biology Market
Synthetic Biology Market: By Tool (XNAS, Chassis Organisms, Oligonucleotides, etc); By Technology (DNA Synthesis & Sequencing, Computational Modelling, Bioinformatics, Microfluidics, etc); By Application (Environmental, Medical, Industrial, etc); By Geography - (2015-2023)
Report Code : HCR 0086
Published: 21 August, 2016   20% discount on this report
15

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Synthetic Biology industry refers to the application of engineering principles to the fundamental components of Biology. It involves the concepts of various subjects like genetic engineering, biotechnology, biophysics, computer engineering, molecular biology, and evolutionary biology. Synthetic biology exactly deals with the design and fabrication of biological components that does not exist and also the redesign of the existing biological components. It creates an artificial life using unnatural components. It also uses natural components and assembles them into a system that acts unnaturally. Synthetic biology majorly involves the activities such as DNA coding, synthetic genes, bioinformatics, processing of various biological components, genome engineering and so on. 

Synthetic Biology Market

Synthetic Biology market is segmented based on tools, technology, applications and geography. Tools considered in the report are Xeno-Nucleic Acids (Xnas), Chassis Organisms, Oligonucleotides, Cloning Technology Kits and Enzymes. Researchers and companies involved in synthetic biology are synthesizing enzymes with high activity to produce products with optimal yields and effectiveness. Various technologies in biotechnology includes DNA Synthesis, DNA sequencing, Computational Modelling, Bioinformatics Technologies, Microfluidics Technologies, Nanotechnology, Pathway Engineering and others. The market report also provides analysis of synthetic biology applications in environmental, medical and industrial sectors. Rising demand for improved drugs and vaccines has been attracting investments globally into the healthcare sector. The synthetic biology market is thus set to witness significant growth in coming years owing to the strong investments from both public and private sector. 

Sample Companies Profiled in this Report are:
  • Intrexon Corporation (U.S)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Amyris Inc (U.S.)
  • GenScript Biotech Corporation (China)
  • Synthetic Genomics Inc (U.S.). 
  • 10+

The other companies in the market held low share owing to the high entry barrier in the market and capital intensiveness for research and development. 
1.Synthetic Biology Market Overview
2.Synthetic Biology Market Executive Summary
3.Synthetic Biology Market Landscape
   3.1.Market share Analysis
   3.2.End User Profiling
   3.3.Competitor Benchmarking
   3.4.Financial Analysis
4.Synthetic Biology Market Forces
   4.1.Market Drivers
      4.1.1.Strong Investments in Synthetic Biology 
      4.1.2.Developments in Production of Bio-Based Chemicals and Fuels
      4.1.3.Rising Demand for Improved Drugs and Vaccines
      4.1.4.Advancement in Molecular Biology
      4.1.5.Wide Spread Application of Synthetic Biology 
   4.2.Market Challenges/Constraints
      4.2.1.Rising Biosecurity Issues
      4.2.2.Ethical Concerns and Stringent Regulations
   4.3.Attractiveness of the Synthetic Biology Market
      4.3.1.Power of Suppliers
      4.3.2.Power of Customers
      4.3.3.Threat of New entrants
      4.3.4.Threat of Substitution
      4.3.5.Degree of Competition
5.Synthetic Biology Market – Strategic Analysis
   5.1.Value Chain Analysis
   5.2.Pricing Analysis
   5.3.Opportunity Analysis
      5.3.1.Rising Concerns on Fuel Consumption
      5.3.2.Growing Demand for Therapeutics
   5.4.Market Lifecycle Analysis
6.Synthetic Biology Market – By Tool
   6.1.Introduction
   6.2.Xeno-Nucleic Acids (Xnas)
   6.3.Chassis Organisms
   6.4.Oligonucleotides
   6.5.Cloning Technology Kits
   6.6.Enzymes
7.Synthetic Biology Market – By Technology
   7.1.Introduction
   7.2.DNA Synthesis
   7.3.DNA sequencing
   7.4.Computational Modelling
   7.5.Bioinformatics Technologies
   7.6.Microfluidics Technologies
   7.7.Nanotechnology
   7.8.Pathway Engineering
   7.9.Other
8.Synthetic Biology Market – By Application
   8.1.Introduction
   8.2.Environmental Application
      8.2.1.Bioremediation
      8.2.2.Whole-Cell Biosensors
   8.3.Medical Applications
      8.3.1.Drug Discovery and Therapeutics
      8.3.2.Pharmaceuticals
      8.3.3.Artificial Tissue and Tissue Regeneration
   8.4.Industrial Applications
      8.4.1.Biofuel and Renewable Energy
      8.4.2.Industrial Enzyme
      8.4.3.Biomaterials & Green Chemicals
9.Synthetic Biology Market – By Geography
   9.1.Introduction
   9.2.Americas
      9.2.1.U.S.
      9.2.2.Canada
      9.2.3.Mexico
      9.2.4.Brazil
      9.2.5.Rest of Americas
   9.3.Europe
      9.3.1.U.K.
      9.3.2.Germany
      9.3.3.Italy
      9.3.4.Russia
      9.3.5.Rest of Europe
   9.4.APAC
      9.4.1.China
      9.4.2.South Korea
      9.4.3.Japan
      9.4.4.India
      9.4.5.Rest of APAC
   9.5.RoW
      9.5.1.Middle East 
      9.5.2.Africa
10.Synthetic Biology Market Entropy
11.Synthetic Biology Market - Company Profiles
   11.1.Ingenza Ltd (U.K.)
   11.2.Intrexon Corporation (U.S)
   11.3.Ziopharm Oncology Inc (U.S)
   11.4.Cargill Incorporated (U.S.)
   11.5.Novozymes (Denmark)
   11.6.OriGene Technologies, Inc (U.S.)
   11.7.Green Biologics Limited (U.K.)
   11.8.Evolva (Switzerland)
   11.9.Codexis, Inc. (U.S.)
   11.10.Halozyme Inc. (U.S.)
   11.11.Integrated DNA Technologies, Inc. (U.S.)
   11.12.Thermo Fisher Scientific, Inc. (U.S.)
   11.13.Algenol Biotech (U.S.)
   11.14.Amyris Inc (U.S.)
   11.15.BioAmber Inc (Canada)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
List of Tables:

Table 1: Global Synthetic Biology Market, By Application, 2015-2023 ($Billion) 
Table 2: Synthetic Biology Market Value, By Tools, 2015-2023, ($Billion) 
Table 3: Synthetic Biology Market Value, By Technology, 2015-2023 ($Billion) 
Table 4: Global Synthetic Biology Market Revenue, By Application, 2015-2023 ($Billion) 
Table 5: Global Synthetic Biology Market Value, By Region, 2015 -2023 ($Billion)
Table 6: Americas: Synthetic Biology Market Value, By Country, 2015 -2023 ($Million)
Table 7: Americas: Synthetic Biology Market Value, By Technology, 2015 -2023 ($Million)
Table 8: Americas: Synthetic Biology Market Value, By product, 2015 -2023 ($Million)
Table 9: Americas: Synthetic Biology Market Value, By Application, 2015 -2023 ($Million)
Table 10: Europe: Synthetic Biology Market Value, By Country, 2015 -2023 ($Million)
Table 11: Europe: Synthetic Biology Market Value, By Technology, 2015 -2023 ($Million)
Table 12: Europe: Synthetic Biology Market Value, By product, 2015 -2023 ($Million)
Table 13: Europe: Synthetic Biology Market Value, By Technology, 2015 -2023 ($Million)
Table 14: APAC: Synthetic Biology Market Value, By Country, 2015-2023 ($Million) 
Table 15: APAC: Synthetic Biology Market Value, By Technology, 2015-2023 ($Million) 
Table 16: APAC: Synthetic Biology Market Value, By product, 2015-2023 ($Million) 
Table 17: APAC: Synthetic Biology Market Value, By Application, 2015-2023 ($Million) 
Table 18: RoW: Synthetic Biology Market, By Region, 2015-2023 ($Million) 
Table 19: RoW: Synthetic Biology Market, By Technology, 2015-2023 ($Million) 
Table 20: RoW: Synthetic Biology Market, By Product, 2015-2023 ($Million) 
Table 21: RoW: Synthetic Biology Market, By Application, 2015-2023 ($Million)


List of Figures:

Figure 1: Global Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 2: Global Synthetic Biology Market, By Product, 2015-2023 ($Billion) 
Figure 3: Global Synthetic Biology Market, By Technology, 2015-2023 ($Billion) 
Figure 4: Global Synthetic Biology Market Share, By Region, 2023 (%) 
Figure 5: Synthetic Biology : DNA Synthesis & Sequencing Market Share, By Key Players, 2016 (%)
Figure 6: Global Synthetic Biology Market Share, By End User Application, 2015 (%) 
Figure 7: Thermo Fisher Scientific, Inc. Financials, 2015 ($Million) 
Figure 8: Intrexon Corp Financials, 2015 ($Million) 
Figure 9: Earning Per Share, By Company, 2015 ($) 
Figure 10: Amyris, Inc. Financials, 2015 ($Million) 
Figure 11: Novozyme A/S Financials, 2015 ($Million) 
Figure 12: Xeno-Nucleic Acids: Synthetic Biology Market Value, 2015-2023, ($Billion) 
Figure 13: Chassis Organisms: Synthetic Biology Market Value, 2015-2023, ($Billion) 
Figure 14: Oligonucleotides : Synthetic Biology Market Value, 2015-2023, ($Billion) 
Figure 15: Cloning Technologies Kits: Synthetic Biology Market Value, 2015-2023, ($Billion) 
Figure 16: Enzymes: Synthetic Biology Market Value, 2015-2023, ($Billion) 
Figure 17: DNA Synthesis: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 18: DNA Sequencing: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 19: Computational Modeling: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 20: Bioinformatics Technology: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 21: Microfluidics Technology: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 22: Nanotechnology: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 23: Pathway Engineering: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 24: Others: Synthetic Biology Market Value, 2015-2023 ($Billion) 
Figure 25: Global Synthetic Biology Market Revenue Share, By Application, 2015 (%) 
Figure 26: Environmental: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 27: Bioremediation: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 28: Whole-Cell Biosensors: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 29: Medical: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 30: Drug Discovery and Therapeutics: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 31: Pharmaceuticals: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 32: Artificial Tissue and Tissue Regeneration: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 33: Industrial: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 34: Biofuel and Renewable: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 35: Industrial Enzyme: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 36: Biomaterials & Green Chemicals: Synthetic Biology Market Revenue, 2015-2023 ($Billion) 
Figure 37: U.S.: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 38: U.S.: GDP – Composition of 2015, By Sector of Origin 
Figure 39: U.S.: Export and Import Value, 2012-2015 ($Trillion) 
Figure 40: U.S.: GDP – Composition of 2015, By End Use 
Figure 41: Brazil: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 42: Brazil: GDP – Composition of 2015, By Sector of Origin 
Figure 43: Brazil: Export and Import Value, 2012-2015 ($Billion) 
Figure 44: Brazil: GDP – Composition of 2015, By End Use 
Figure 45: Canada: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 46: Canada: GDP – Composition of 2015, By Sector of Origin 
Figure 47: Canada : Export and Import Value, 2012-2015 ($Billion) 
Figure 48: Canada : GDP – Composition of 2015, By End Use 
Figure 49: Mexico: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 50: Mexico: GDP – Composition of 2015, By Sector of Origin 
Figure 51: Mexico: Export and Import Value, 2012-2015 ($Billion) 
Figure 52: Mexico: GDP – Composition of 2015, By End Use 
Figure 53: Argentina: GDP and Population, 2012-2015 ($Billion, Million) 
Figure 54: Argentina: GDP – Composition of 2015, By Sector of Origin 
Figure 55: Argentina: Export and Import Value, 2012-2015 ($Billion) 
Figure 56: Argentina: GDP – Composition of 2015, By End Use 
Figure 57: U.K.: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 58: U.K.: GDP – Composition of 2015, By Sector of Origin 
Figure 59: U.K.: Export and Import Value, 2012-2015 ($Billion) 
Figure 60: U.K.: GDP – Composition of 2015, By End Use 
Figure 61: Germany: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 62: Germany: GDP – Composition of 2015, By Sector of Origin 
Figure 63: Germany: Export and Import Value, 2012-2015 ($Billion) 
Figure 64: Germany: GDP – Composition of 2015, By End Use 
Figure 65: France: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 66: France: GDP – Composition of 2015, By Sector of Origin 
Figure 67: France: Export and Import Value, 2012-2015 ($Billion) 
Figure 68: France: GDP – Composition of 2015, By End Use 
Figure 69: China: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 70: China: GDP – Composition of 2015, By Sector of Origin 
Figure 71: China: Export and Import Value, 2012-2015 ($Billion) 
Figure 72: China: GDP – Composition of 2015, By End Use 
Figure 73: Japan: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 74: Japan: GDP – Composition of 2015, By Sector of Origin 
Figure 75: Japan: Export and Import Value, 2012-2015 ($Billion) 
Figure 76: Japan: GDP – Composition of 2015, By End Use 
Figure 77: India: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 78: India: GDP – Composition of 2015, By Sector of Origin 
Figure 79: India: Export and Import Value, 2012-2015 ($Billion) 
Figure 80: India: GDP – Composition of 2015, By End Use 
Figure 81: South Korea: GDP and Population, 2012-2015 ($Trillion, Million) 
Figure 82: South Korea: GDP – Composition of 2015, By Sector of Origin 
Figure 83: South Korea: Export and Import Value, 2012-2015 ($Billion) 
Figure 84: South Korea: GDP – Composition of 2015, By End Use 
Figure 85: Synthetic Biology Market Entropy Development Share, By Strategies, 2012-2017* (%) 
Figure 86: Synthetic Biology Market Entropy, By Total Number of Developments, 2012-2017* 
Figure 87: INTREXON CORPORATION, Revenue, 2013-2016 ($Million) 
Figure 88: INTREXON CORPORATION, By Business Segments, 2015 (%) 
Figure 89: Ziopharm Oncology, Inc., Revenue, 2013-2016 ($Million) 
Figure 90: Cargill, Incorporated. – Revenue 2013-2016 ($Million) 
Figure 91: Cargill, Incorporated. Revenue, By Geography, 2015 (%) 
Figure 92: Cargill, Incorporated: Development 
Figure 93: Novozymes – Revenue 2013-2016 ($Million) 
Figure 94: Novozymes – Revenue($Million) by Geography 
Figure 95: Novozymes – Revenue($Million) by Business Segments 
Figure 96: Evolva Revenue, 2013-2015 ($Million) 
Figure 97: Evolva Revenue Share, By Geography, 2015 (%) 
Figure 98: Evolva Business Segment Market Share, 2015 (%) 
Figure 99: Codex is, Inc. Revenue, 2013-2015 ($Million) 
Figure 100: Halozyme, Inc., Revenue, 2013-2015 ($Million) 
Figure 101: Halozyme, Inc. Revenue, By Geography, 2015 (%) 
Figure 102: Thermo Fisher Scientific, Inc. Revenue, 2013-2015 ($Billion) 
Figure 103: Thermo Fisher Scientific, Inc., By Business Segment, 2015 (%) 
Figure 104: Amyris Inc. Revenue, 2012-2015 ($Million) 
Figure 105: Amyris Inc. Revenue, By Geography, 2015 (%) 
Figure 106: BioAmber Inc. Revenues 2011-2015 ($Million) 
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll